GSE123712
XmaI-RRBS on triple negative breast carcinoma samples taken prior to chemotherapy
Triple negative breast carcinoma samples were taken prior to chemotherapy in order to identify epigenomic profiles predictive of neoadjuvant chemotherapy efficacy Overall design: Reduced representation bisulfite sequencing by XmaI-RRBS (Tanas et al., 2017)